Skip to search formSkip to main contentSkip to account menu

Solifenacin

Known as: 2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-,1- azabicyclo(2.2.2)oct-3-yl ester, (R-(R*,S*))- 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

VesicareYM905
solifenacin succinatesolifenacin succinate 5 MG Oral Tablet [Vesicare]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Tamsulosin combined with solifenacin versus tamsulosin monotherapy for male lower urinary tract symptoms: a meta-analysis
Abstract Objective: To evaluate the efficacy and safety of tamsulosin and solifenacin combination therapy compared with… 
2013
2013
Cost-Effectiveness of Mirabegron Compared with Antimuscarinic Agents for the Treatment of Adults with Overactive Bladder in the United Kingdom.
Highly Cited
2011
Highly Cited
2011
Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy
To investigate the serum nerve growth factor (NGF) and urinary NGF levels in patients with overactive bladder syndrome (OAB… 
2011
2011
Evaluation of Brain Anticholinergic Activities of Urinary Spasmolytic Drugs Using a High‐Throughput Radio Receptor Bioassay
OBJECTIVES: To compare the brain anticholinergic activities of five urinary spasmolytic drugs (USDs). 
2011
2011
Tolerability of solifenacin and oxybutynin immediate release in older (>65 years) and younger (≤65 years) patients with overactive bladder: sub-analysis from a Canadian, randomized, double-blind…
Abstract Objective: Overactive bladder (OAB) is a common condition whose prevalence increases with age. Antimuscarinic agents are… 
2011
2011
Low persistence of anticholinergic drug use in Sweden
Highly Cited
2008
Highly Cited
2008
Cardiovascular Safety and Overall Tolerability of Solifenacin in Routine Clinical Use
AbstractBackground: Muscarinic receptor antagonists are the standard of care for patients with overactive bladder (OAB). However… 
2008
2008
Human urine with solifenacin intake but not tolterodine or darifenacin intake blocks detrusor overactivity
The objective of the study was to evaluate the local effects of three antimuscarinics excreted into human urine after oral… 
2006
2006
Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin
The embarrassment and social stigma associated with urinary incontinence (UI) in overactive bladder syndrome (OAB) sufferers is a… 
Review
2006
Review
2006
Pharmacologic management of overactive bladder: practical options for the primary care physician.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)